Celyad Oncology S.A.
CLYYF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $7 | $12 | $30 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $0 | $1 | $2 |
| Inventory | $0 | $1 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $1 | $2 |
| Total Curr. Assets | $7 | $11 | $15 | $34 |
| Property Plant & Equip (Net) | $1 | $2 | $0 | $3 |
| Goodwill | $0 | $0 | $0 | $1 |
| Intangibles | $0 | $0 | $1 | $35 |
| Long-Term Investments | $1 | $3 | $0 | $2 |
| Tax Assets | $0 | $0 | $0 | -$2 |
| Other NC Assets | $0 | $0 | $4 | $6 |
| Total NC Assets | $3 | $5 | $5 | $46 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $10 | $16 | $20 | $80 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $5 | $7 |
| Short-Term Debt | $0 | $0 | $0 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $1 | $1 |
| Other Curr. Liab. | $1 | $2 | $4 | $4 |
| Total Curr. Liab. | $3 | $3 | $10 | $14 |
| LT Debt | $17 | $1 | $0 | -$13 |
| Deferred Rev, NC | $4 | $5 | $5 | $6 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $15 |
| Other NC Liab. | $2 | $2 | $0 | $15 |
| Total NC Liab. | $23 | $24 | $5 | $22 |
| Other Liabilities | $0 | -$17 | $0 | $0 |
| Cap. Leases | $1 | $1 | $0 | $3 |
| Total Liabilities | $26 | $10 | $15 | $36 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $8 | $33 | $79 | $79 |
| Retained Earnings | -$364 | -$358 | -$350 | -$309 |
| AOCI | $340 | $332 | $269 | $268 |
| Other Equity | $0 | $0 | $6 | $6 |
| Total Equity | -$16 | $6 | $4 | $44 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $10 | $16 | $20 | $80 |
| Net Debt | $13 | -$6 | -$12 | -$41 |